BioPharma
Vinay Prasad Leaves the FDA – An Abrupt End...
The head of the Food and Drug Administration office, overseeing vaccines and gene therapy, Vinay Prasad leaves the FDA after taking over his job just...
BioPharma
AstraZeneca plans to invest $50 billion in America for...
AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is...
BioPharma
AI in Genomics Market – Setting Pace for Vast...
There is no shred of doubt that artificial intelligence in genomics is indeed reshaping the healthcare spectrum, offering unmatched opportunities to decode the intricacies of...
BioPharma
Future Innovations In Pharmaceutical Packaging Post-2025
Because of new ideas, concerns about safety for consumers, and government rules, the pharmaceutical business is about to enter a new era in packing. As...
BioPharma
Protein Antibody Development: How To Choose The Best CDMO
Selecting the appropriate contract research and manufacturing option is crucial for biopharmaceutical companies starting new initiatives related to the creation of novel antibodies.
Biopharma companies are...
BioPharma
CDMOs and Advanced Technologies in Biopharma Manufacturing
The biopharmaceutical sector is driven by rising global healthcare needs, technology, technological advancements, and the imperative to remain agile in a highly regulated environment. The...
BioPharma
Biopharma Production with AI: A New Era in Manufacturing
A New Era of Biopharma Production with AI
The biopharma industry is undergoing a transformation as it capitalises on the potential of artificial intelligence (AI) to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.